Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation
- 1 February 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (2) , 427-433
- https://doi.org/10.1016/s0360-3016(00)01488-7
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Epidermal Growth Factor Receptor Inhibition in Cancer Therapy: Biology, Rationale and Preliminary Clinical ResultsInvestigational New Drugs, 1999
- Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient SurvivalJNCI Journal of the National Cancer Institute, 1998
- Downmodulation of TGF-α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cellsJournal of Cellular Biochemistry, 1998
- Epidermal Growth Factor Receptor Family and ChemosensitizationJNCI Journal of the National Cancer Institute, 1997